Latest News & Features
Refine Search
Biotechnology
Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for cancer diagnostics. 13 June 2024
Biotechnology
Finnish health tech firm says Ultrahuman’s motion to stay would significantly prejudice case | Oura claims Indian company trying to circumvent ITC exclusion order. 13 June 2024
Big Pharma
New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies. 13 June 2024
Big Pharma
Court grants temporary restraining order against defendants following Roche allegations | Company claims India-based counterfeiters selling low-quality diabetes test products on Amazon. 13 June 2024
Biotechnology
Illumina and Molecular Loop have filed complaints over DNA testing innovations | Illumina said one Molecular Loop patent was unenforceable due to ‘inequitable conduct’ 11 June 2024
Big Pharma
Victory for Amneal Pharmaceuticals as court dismisses infringement claims | Decision orders Teva to remove patents covering its breathing drug from the FDA's Orange Book | Paves the way for Amneal's generic version. 11 June 2024
Careers
Latest addition to the firm brings medtech expertise and experience assisting digital health companies using AI and machine learning | Move comes at a time when “health care companies are thinking more like technology companies”. 6 June 2024
Big Pharma
Swiss multinational claims Trividia infringed two patents | Roche says former employees with knowledge of patents joined Sinocare subsidiary. 6 June 2024
Biotechnology
Complaint sought judicial validation of the company's patent claims for a distributive shock treatment | Disputes the PTAB's decision deeming the invention obvious. 6 June 2024
article
Court seen as “exceeding expectations” | Experts urge caution, emphasising that confident and reliable court judgments are needed | High-stakes patent litigation, especially in pharmaceuticals, remains predominantly within national courts. 4 June 2024